Mechanism of inhibition of hepatic bioactivation of paracetamol by dimethyl sulfoxide

Research output: Contribution to journalArticlepeer-review


Prior work has shown that DMSO inhibits paracetamol hepatotoxicity. In this paper we show that DMSO and its reduced metabolite dimethyl sulfide (DMS) can inhibit in vitro hepatic dimethylnitrosamine N-demethylase. We also show that DMSO can inhibit in vivo production of glutathione conjugates of paracetamol. Glutathione is known to conjugate the bioactivated form of paracetamol. Also, the isozyme of cytochrome P-450 responsible for dimethylnitrosomine N-demethylase, cytochrome P-450j, is thought responsible for paracetamol bioactivation. We therefore propose that DMSO inhibits paracetamol hepatotoxicity due to inhibition of cytochrome P-450j-dependent paracetamol bioactivation by DMSO and its metabolite DMS.

Original languageEnglish (US)
Pages (from-to)413-424
Number of pages12
JournalDrug Metabolism and Drug Interactions
Issue number3-4
StatePublished - Dec 1988

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)


Dive into the research topics of 'Mechanism of inhibition of hepatic bioactivation of paracetamol by dimethyl sulfoxide'. Together they form a unique fingerprint.

Cite this